HIGHLIGHTS
- who: Barbara Bailly-Caillu00e9 et al. from the Department of Dermatology, Caen-Normandie University Hospital, Caen, France have published the paper: Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study, in the Journal: (JOURNAL) of 31/08/2021
- what: The authors report a quicker favourable To the knowledge , this is the first real-life retrospective study to investigate concomresponse to cemiplimab with a median time to response of 3 months in the concomitant itant radiotherapy to cemiplimab underlying that the abscopal effect . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.